Startup Trucode Gene Repair gained $34 million from a funding round that the company will use to support further research to advance the development of its gene-editing technology that uses a nanoparticle instead of CRISPR/Cas9's engineered virus, thus decreasing the risk for off-target effects.
$34M from funding round to advance Trucode's novel gene-editing system
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.